Research article
Therapeutic basis of glycyrrhizin on chronic hepatitis B

https://doi.org/10.1016/0166-3542(96)00942-4Get rights and content

Abstract

Glycyrrhizin, a major component of a herb (licorice), has been intravenously used for the treatment of chronic hepatitis B in Japan and improves liver function with occasional complete recovery from hepatitis. This substance modifies the intracellular transport and suppresses sialylation of hepatitis B virus (HBV) surface antigen (HBsAg) in vitro. This study was designed to clarify the pharmacological basis for its effectiveness. The structure-bioactivity relationship of glycyrrhizin, glycyrrhetic acid 3-O-monoglucuronide and glycyrrhetic acid was determined, and glycyrrhetic acid was found to be the most active of them. The amounts of three substances bound to the liver were evaluated in guinea pigs after intravenous administration of glycyrrhizin. Glycyrrhizin and glycyrrhetic acid 3-O-monoglucuronide were detected at concentrations of 31.8-1.3 μg/g of liver, but glycyrrhetic acid was not detected. When glycyrrhizin attained these concentrations in the cellular fraction of the PLC/PRF/5 cell culture, it suppressed the secretion of HBsAg as reported previously. These results indicated that glycyrrhizin administered intravenously might bind to hepatocytes at the concentration at which glycyrrhizin could modify the expression of HBV-related antigens on the hepatocytes and suppress sialylation of HBsAg.

References (26)

  • R.S.H. Finney et al.

    The anti-inflammatory activity of glycyrrhetinic acid and derivatives

    J. Pharm. Pharmcol.

    (1958)
  • K. Fujisawa et al.

    Therapeutic approach to chronic active hepatitis with glycyrrhizin

    Asian Med. J.

    (1973)
  • S. Ishida et al.

    Prediction of glycyrrhizin disposition in rat and man by a physiologically based pharmacokinetic model

    Chem. Pharm. Bull.

    (1990)
  • Cited by (0)

    1

    Present address: Ophthalmic Research Division, Santen Pharmaceutical Co., Ltd., Osaka, Japan.

    View full text